Fiber's Utilization for Energy and Life
FUEL
1 other identifier
interventional
19
1 country
1
Brief Summary
The study aims to evaluate the metabolizable energy of the typical American diet with and without the inclusion of fiber. We hypothesize that including fiber in the diet will decrease the metabolizable energy of the diet resulting in more nutrient loss into the feces and urine.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started May 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 13, 2023
CompletedFirst Submitted
Initial submission to the registry
May 16, 2023
CompletedFirst Posted
Study publicly available on registry
July 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2024
CompletedDecember 6, 2023
December 1, 2023
7 months
May 16, 2023
December 4, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Metabolizable Energy of the Diet
The diets provided to participants will be analyzed for their energy and proximate analysis. Fecal and urine samples will be collected for 5 days during week 2 of each intervention period to calculate the total metabolizable energy of the diet. Energy and proximate analysis (dry matter, organic matter, crude protein, acid-hydrolyzed fat, and total dietary fiber) will be analyzed from the provided diet and the fecal samples. Energy will be analyzed from urine samples. The metabolizable energy content will be calculated according to the methods of Novotny et al. (2012), which considers the energy of the diet compared to the remaining energy in the collected fecal and urine samples.
during the last 5 days of the 2 week intervention period
Secondary Outcomes (1)
Fecal Microbiota
end of week 2 (end of intervention period)
Other Outcomes (4)
Gastrointestinal Tolerance
daily during the second week of each intervention period
Bowel Function
week 2 of each intervention period
Stool Consistency
daily during the second week of each intervention period
- +1 more other outcomes
Study Arms (2)
Intervention Treatment
EXPERIMENTALExperimental treatment will contain a cereal product that contains a dietary fiber. This will be consumed three times daily for two weeks.
Control treatment
PLACEBO COMPARATORControl treatment will contain a corn meal cereal product that will be consumed three times daily for two weeks.
Interventions
Eligibility Criteria
You may qualify if:
- Adults ages 22-75 years
- BMI between 18.5 and 39.9 kg/m2
- Ability to drop-off 1 fecal sample within 15 minutes of defecation
- Ability to pick-up meals daily
- Ability to collect fecal and urine samples daily
- Fasting glucose of \<126 mg/dL
You may not qualify if:
- Wheat allergy or intolerance
- Any food allergies or intolerances
- Prior diagnosis of metabolic or gastrointestinal disease (kidney disease, liver disease, gout, hyperthyroidism, untreated or unstable hypothyroidism, certain cancers, gastrointestinal disease, pancreatic disease, diabetes requiring medication)
- Women that are pregnant, had a baby within the last 12 months, or are lactating.
- Individuals that smoke, use tobacco, abuse drugs, or consume \> 2 alcoholic beverages per day.
- \>5% weight change in the past month or \>10% change in the past year
- Oral antibiotics during the previous 6 weeks
- History of malabsorptive or restrictive bariatric surgeries (e.g., gastric bypass, sleeve gastrectomy, adjustable gastric band) or gall bladder removal surgery
- Are unable or unwilling to consume the experimental meals/snacks.
- Taking certain medications (Orlistat, bile binding resins, insulin, oral hypoglycemic agents, laxatives)
- Concurrent enrollment in another dietary, exercise, or medication study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Edward R Madigan Laboratory
Urbana, Illinois, 61801, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 16, 2023
First Posted
July 6, 2023
Study Start
May 13, 2023
Primary Completion
December 1, 2023
Study Completion
May 1, 2024
Last Updated
December 6, 2023
Record last verified: 2023-12
Data Sharing
- IPD Sharing
- Will not share